Head-to-head · WeighScore
KERNX Health vs Teleios Health
The verdict
KERNX Health takes it — 62.2/100 to 60.2/100, but only just.
KERNX Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit. Teleios Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | KERNX Health | Teleios Health |
|---|---|---|
| WeighScore | 62.2/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #276 | #327 |
| Semaglutide | $129/mo (promotional rate, plus a separate fee, compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide | $199/mo (promotional rate, plus a separate fee, compounded) | $139/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #276 · C
Strengths
- Publishes plan pricing openly, before any intake or account creation
- Month-to-month with no long-term contract and no multi-month prepayment
- Billing starts only after a licensed provider approves treatment
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
- The consultation fee is charged whether or not a prescription is issued
- Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
- No compounding pharmacy is named anywhere on the site
- Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
Graded #327 · C
Strengths
- Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
- Compounded tirzepatide from a competitive $139/mo floor
- Markets physician (MD/DO) prescribing rather than an NP-only model
- Clean meta-tag and SEO implementation
Where it loses points
- Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
- No named medical director, physician, or corporate entity disclosed
- Year founded unknown — a newer floor-price entrant warranting extra scrutiny
- No LegitScript, NABP, or SOC 2 trust signal found
- Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.